Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk by Alejo, Jennifer L, Kim, Jake D, Chiang, Teresa P Y, Avery, Robin K, Karaba, Andrew H, Jefferis, Alexa, Warren, Daniel S, Massie, Allan B, Tobian, Aaron A R, Segev, Dorry L, Werbel, William A

Get full text

Letter to the editor: “hook” (prozone) effect in sars‐cov‐2 anti‐spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant re... by Abedon, Aura T., Chiang, Teresa P. Y., Karaba, Andrew H., Alejo, Jennifer L., Chahoud, Margaret, Hussey, Casey, Lopes, Jessica F., Hussain, Sarah, Larsen, Christian P., Durand, Christine M., Heeger, Peter S., Segev, Dorry L., Clarke, William A., Werbel, William A.

Get full text

6‐month antibody kinetics and durability after four doses of a SARS‐CoV‐2 vaccine in solid organ transplant recipients by Mitchell, Jonathan, Chiang, Teresa PY, Alejo, Jennifer L., Kim, Jake D., Chang, Amy, Abedon, Aura T., Avery, Robin K., Tobian, Aaron A. R., Levan, Macey L., Warren, Daniel S., Garonzik‐Wang, Jacqueline M., Segev, Dorry L., Massie, Allan B., Werbel, William A.

Get full text

Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses by Chang, Amy, Chiang, Teresa Py, Kim, Jake D, Mitchell, Jonathan, Alejo, Jennifer L, Jefferis, Alexa A, Avery, Robin K, Tobian, Aaron A R, Levan, Macey L, Warren, Daniel S, Garonzik-Wang, Jacqueline M, Massie, Allan B, Segev, Dorry L, Werbel, William A

Get full text